DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

MS Contin (Morphine) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (37)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to MS Contin (Morphine) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 37   Next >>

Possible MS Contin side effects in 38 year old male

Reported by a consumer/non-health professional from Australia on 2012-06-27

Patient: 38 year old male, weighing 149.0 kg (327.8 pounds)

Reactions: Fatigue, Snoring, Arteriosclerosis Coronary Artery, Toxicity To Various Agents, Drug Abuse, Cardiomegaly, Hepatic Steatosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Diazepam
    Dosage: unk
    Indication: Back Pain

MS Contin
    Dosage: 160 mg, 1x/day

Clonazepam
    Indication: Anxiety

MS Contin
    Dosage: 100 mg, 1x/day
    Indication: Pain

Diazepam
    Indication: Anxiety

Alprazolam
    Dosage: unk
    Indication: Back Pain

Alprazolam
    Indication: Agitation

Clonazepam
    Indication: Agitation

Clonazepam
    Dosage: unk
    Indication: Back Pain

Alprazolam
    Indication: Anxiety

Diazepam
    Indication: Agitation

Other drugs received by patient: Codeine; Zuclopenthixol; Metoclopramide



Possible MS Contin side effects in 38 year old male

Reported by a physician from Australia on 2012-06-26

Patient: 38 year old male, weighing 149.0 kg (327.8 pounds)

Reactions: Fatigue, Snoring, Arteriosclerosis Coronary Artery, Toxicity To Various Agents, Drug Abuse, Cardiomegaly, Hepatic Steatosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Alprazolam
    Indication: Agitation

Clonazepam
    Indication: Back Pain

Alprazolam
    Dosage: unk
    Indication: Back Pain

Diazepam
    Indication: Agitation

Alprazolam
    Indication: Anxiety

MS Contin
    Dosage: 100 mg, 1x/day
    Indication: Pain

Clonazepam
    Indication: Agitation

Diazepam
    Indication: Back Pain

Clonazepam
    Indication: Anxiety

MS Contin
    Dosage: 160 mg, 1x/day

Diazepam
    Indication: Anxiety

Other drugs received by patient: Zuclopenthixol; Metoclopramide; Codeine



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-05-17

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin
    Dosage: 900 mg, unk

MS Contin
    Dosage: 600 mg, unk



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-05-15

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 83 year old female

Reported by a physician from Canada on 2012-05-03

Patient: 83 year old female

Reactions: Drug Administration Error, Accidental Exposure

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-04-16

Patient: male

Reactions: Confusional State, Prostate Cancer Metastatic, Multiple Drug Overdose, Respiratory Depression, Drug Abuse

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01

Morphine Sulfate
    Dosage: 30 mg, every 4-6 hours as needed
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01



Possible MS Contin side effects in

Reported by a pharmacist from United States on 2012-04-13

Patient:

Reactions: Weight Decreased, Abdominal Pain, Dyspnoea, Nausea, Fatigue, Dyspnoea Exertional, Syncope, Pancreatic Carcinoma Metastatic, Liver Function Test Abnormal, Dehydration, Oedema

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Tracleer
    Dosage: 125 mg, bid
    Administration route: Oral
    Start date: 2012-03-08
    End date: 2012-03-28

Tracleer
    Dosage: 125 mg, bid
    Administration route: Oral
    End date: 2012-01-01

Tracleer
    Dosage: 62.5 mg, bid
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2008-02-21

Tracleer
    Dosage: 62.5 mg, bid
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-03-07

MS Contin

Other drugs received by patient: Aspirin; Plavix; Sucralfate; Nitroglycerin; Gemcitabine; Mycophenolate Mofetil (Cellcept); Mupirocin; Ambien; Lexapro; Zofran



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-04-11

Patient: male

Reactions: Confusional State, Prostate Cancer Metastatic, Respiratory Depression, Multiple Drug Overdose, Drug Abuse

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01

Morphine Sulfate
    Dosage: 30 mg, q4- 6h prn
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01



Possible MS Contin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02

Patient: female

Reactions: Pulmonary Hypertension, Biliary Tract Operation, Drug Ineffective, Pancreatic Neoplasm, Death, Hepatic Encephalopathy, Oesophagitis, Cholangitis, Pancreatitis Chronic, Gastrooesophageal Reflux Disease, Renal Failure Acute, Dysphagia, Metabolic Acidosis, Type 2 Diabetes Mellitus, Hypotension, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Diarrhoea, Liver Transplant Rejection, Feeling Abnormal, Hypertension, Herpes Virus Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin
    Dosage: unk
    Indication: Pain

Prograf
    Dosage: 0.5 unk, q3d
    Start date: 2012-01-01
    End date: 2012-01-29

Prograf
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 1997-07-08
    End date: 2012-01-01

Lactulose
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Diflucan; Sodium Bicarbonate; Carafate; Morphine; Oxycodone HCL; Xifaxan; MAG-OX; Protonix; Insulin; Creon; Metoprolol Succinate



Possible MS Contin side effects in 53 year old male

Reported by a physician from China on 2012-03-28

Patient: 53 year old male

Reactions: Respiratory Depression

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-21

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-19

Patient: female

Reactions: Pulmonary Hypertension, Biliary Tract Operation, Drug Ineffective, Pancreatic Neoplasm, Death, Hepatic Encephalopathy, Oesophagitis, Cholangitis, Pancreatitis Chronic, Gastrooesophageal Reflux Disease, Renal Failure Acute, Type 2 Diabetes Mellitus, Dysphagia, Metabolic Acidosis, Hypotension, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Diarrhoea, Liver Transplant Rejection, Hypertension, Feeling Abnormal, Herpes Virus Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prograf
    Dosage: 0.5 unk, q3d
    Start date: 2012-01-01
    End date: 2012-01-29

Prograf
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 1997-07-08
    End date: 2012-01-01

Lactulose
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

MS Contin
    Dosage: unk
    Indication: Pain

Other drugs received by patient: Morphine; Oxycodone HCL; Metoprolol Succinate; Creon; Xifaxan; Protonix; Sodium Bicarbonate; Insulin; MAG-OX; Diflucan; Carafate



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in

Reported by a physician from Canada on 2012-03-15

Patient:

Reactions: Overdose, Drug Prescribing Error

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in

Reported by a physician from Canada on 2012-03-12

Patient:

Reactions: Overdose, Drug Prescribing Error

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 79 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-12

Patient: 79 year old male

Reactions: Confusional State, Overdose, Urinary Tract Infection, Urosepsis, Aggression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin



Possible MS Contin side effects in 76 year old male

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: 76 year old male, weighing 123.0 kg (270.6 pounds)

Reactions: Dyspnoea, Pleuritic Pain, Lung Infection, Lymphopenia, Hyponatraemia, Anxiety, Fatigue, Dehydration, Neutropenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fentanyl-100

MS Contin

Taxol
    Dosage: last adminstered dose:7dec11,462mg on 17jan12
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-11-15
    End date: 2012-01-17

Carboplatin
    Dosage: last administered dose:7dec11,691mg on 17jan12
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-11-15
    End date: 2012-01-17



Possible MS Contin side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-07

Patient: 65 year old male

Reactions: Abdominal Pain, Large Intestine Perforation, Nausea, Lung Cancer Metastatic, Constipation, Infectious Peritonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dalteparin Sodium
    Dosage: unk
    Indication: Lung Neoplasm Malignant
    Start date: 2010-12-20
    End date: 2011-02-25

Aprepitant
    Dosage: unk
    Start date: 2011-02-25
    End date: 2011-02-25

Dexamethasone
    Dosage: 4 mg, unk
    Administration route: Oral
    End date: 2011-02-25

Cisplatin
    Dosage: unk
    Start date: 2010-12-21
    End date: 2011-02-25

Ondansetron
    Dosage: 8 mg, unk
    Administration route: Oral

MS Contin
    Dosage: 30 mg, unk
    Administration route: Oral

Pemetrexed Disodium
    Dosage: unk
    Start date: 2010-12-21
    End date: 2011-02-25

Other drugs received by patient: Acetaminophen; Piperacillin and Tazobactam



Possible MS Contin side effects in 76 year old male

Reported by a consumer/non-health professional from United States on 2012-03-06

Patient: 76 year old male, weighing 123.0 kg (270.6 pounds)

Reactions: Anxiety, Fatigue, Dyspnoea, Pleuritic Pain, Dehydration, Lung Infection, Lymphopenia, Hyponatraemia, Neutropenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fentanyl-100

Taxol
    Dosage: last adminstered dose:7dec11,462mg on 17jan12
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-11-15
    End date: 2012-01-17

MS Contin

Carboplatin
    Dosage: last administered dose:7dec11,691mg on 17jan12
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-11-15
    End date: 2012-01-17



Possible MS Contin side effects in 84 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-01-31

Patient: 84 year old female

Reactions: Wrong Drug Administered, Product Label Confusion

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin
    Dosage: 60 mg, unk
    Administration route: Oral

Darvon-N
    Administration route: Oral



Possible MS Contin side effects in 84 year old female

Reported by a consumer/non-health professional from Canada on 2012-01-27

Patient: 84 year old female

Reactions: Wrong Drug Administered, Product Label Confusion

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Darvon-N
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-01-05

Patient: male, weighing 48.7 kg (107.1 pounds)

Reactions: Abdominal Pain Lower, Hypoglycaemia, General Physical Health Deterioration, Loss of Consciousness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin

Bevacizumab (Rhumab Vegf)
    Dosage: 224 mg
    End date: 2011-11-22

Leucovorin Calcium
    Dosage: 655 mg

Fluorouracil
    Dosage: 3585 mg
    End date: 2011-11-22

Irinotecan HCL
    Dosage: 229 mg
    End date: 2011-11-22

Other drugs received by patient: Princess Margaret Hosp. Mouthwash; Senokot; Betamethasone; Granisetron; Colace; Gabepentin; Decadron; Stemetil; Fentanyl-100; Lactulase; Simvastatin



Possible MS Contin side effects in male

Reported by a physician from United Kingdom on 2011-12-22

Patient: male, weighing 69.0 kg (151.8 pounds)

Reactions: Respiratory Arrest, Toxicity To Various Agents, Epilepsy, Accidental Overdose

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin
    Dosage: 20 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2006-01-17

Morphine Sulfate
    Dosage: 80 mg, daily
    Administration route: Oral
    Indication: Pain

Clobazam
    Dosage: 20 mg, bid
    Indication: Convulsion

Other drugs received by patient: Trileptal; Buprenorphine; Benzodiazepine Derivatives; Epanutin / 00017401 /; Prozac; Zanaflex; Temazepam



Possible MS Contin side effects in 32 year old male

Reported by a physician from United Kingdom on 2011-12-21

Patient: 32 year old male, weighing 69.0 kg (151.8 pounds)

Reactions: Respiratory Arrest, Toxicity To Various Agents, Accidental Overdose, Epilepsy

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin
    Dosage: 20 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2006-01-17

Morphine Sulfate
    Dosage: 80 mg, daily
    Administration route: Oral
    Indication: Pain

Clobazam
    Dosage: 20 mg, 2x/day
    Indication: Convulsion

Other drugs received by patient: Buprenorphine; Trileptal; Zanaflex; Prozac; Temazepam; Phenytoin Sodium



Possible MS Contin side effects in 40 year old male

Reported by a physician from Hungary on 2011-12-08

Patient: 40 year old male

Reactions: Weight Decreased, Jaundice, Anaemia, Hypotension, Coma, Neoplasm Progression, Disorientation, Hepatic Enzyme Increased, Convulsion, Therapeutic Response Decreased, Urinary Retention, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Morphine
    Indication: Cancer Pain

MS Contin
    Administration route: Oral

Fentanyl-100
    End date: 2010-10-01

MS Contin
    Administration route: Oral
    Indication: Cancer Pain

Fentanyl-100
    End date: 2010-04-01

Fentanyl-100

Fentanyl-100

Nsaid
    Indication: Pain

MS Contin
    Administration route: Oral

Amitriptyline HCL
    Indication: Pain

MS Contin
    Administration route: Oral

Hydromorphone HCL
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Fentanyl-100
    Indication: Cancer Pain

Fentanyl-100
    Start date: 2010-06-01

Gemcitabine
    Indication: Chemotherapy

Cisplatin
    Indication: Chemotherapy



Possible MS Contin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-23

Patient: male

Reactions: Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
MS Contin

Norco
    Indication: Neoplasm Malignant



Possible MS Contin side effects in 40 year old male

Reported by a physician from Hungary on 2011-11-18

Patient: 40 year old male

Reactions: Jaundice, Weight Decreased, Hypotension, Anaemia, Neoplasm Progression, Coma, Disorientation, Hepatic Enzyme Increased, Convulsion, Therapeutic Response Decreased, Urinary Retention, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Hydromorphone HCL
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Fentanyl-100

Gemcitabine
    Indication: Chemotherapy

Cisplatin
    Indication: Chemotherapy

Fentanyl-100
    Indication: Cancer Pain

Fentanyl-100
    End date: 2010-10-01

Morphine
    Indication: Cancer Pain

Amitriptyline HCL
    Indication: Pain

Nsaid
    Indication: Pain

MS Contin
    Administration route: Oral

MS Contin
    Administration route: Oral

Fentanyl-100

Fentanyl-100
    Start date: 2010-06-01

MS Contin
    Administration route: Oral

Fentanyl-100
    End date: 2010-04-01

MS Contin
    Administration route: Oral
    Indication: Cancer Pain



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017